Moderna Trial Shows High Efficacy Against Coronavirus 6 Months After Vaccination

Moderna released findings on Tuesday from its phase three trial which showed that its coronavirus vaccine is 90% effective at preventing infections and more than 95% effective against severe disease up to six months after the second dose.